Form 8 (DD) - Spire Healthcare Group plc
Harbant Samra, acting in concert with Spire Healthcare Group plc, has disclosed interests in the company's ordinary shares, holding 74,932 shares representing 0.02% of the class, with no short positions. Additionally, Samra holds options under various Long Term Incentive and Deferred Share Bonus Plans, with some options subject to performance conditions and holding periods. Samra also exercised share awards under the 2023 Long Term Incentive Plan, resulting in the net allocation of 19,855 ordinary shares after tax settlement. No other dealings or relevant agreements were disclosed.
Select text to share a quote on X · sign in to keep highlights & notes in your SPI notes
KEY INFORMATION
| (a) Full name of discloser: | Harbant Samra | |||
| (d) Status of person making the disclosure: e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree) | Person acting in concert with the offeree (Spire Healthcare Group plc) | |||
| (e) Date dealing undertaken: | 18 May 2026 | |||
| 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE | ||||
| Class of relevant security: | Ordinary shares of 1 pence each | |||
| Interests | Short positions | |||
| Number | % | Number | % | |
| (1) Relevant securities owned and/or controlled: | 74,932 | 0.02 | Nil | - |
| (2) Cash-settled derivatives: | Nil | - | Nil | - |
| (3) Stock-settled derivatives (including options) and agreements to purchase/sell: | Nil | - | Nil | - |
| TOTAL: | 74,932 | 0.02 | Nil | - |
All interests and all short positions should be disclosed.
- Rights to subscribe for new securities (including directors' and other employee options)
| Class of relevant security in relation to which subscription right exists: | Ordinary shares of 1 pence each |
| Details, including nature of the rights concerned and relevant percentages: | Scheme under which granted Number of ordinary shares in respect of which options granted Date of grant Exercise price per share (£) Vesting date Expiry / lapse date 2024 Long Term Incentive Plan 320,675* 15 May 2024 Nil 14 March 2027** 13 March 2034 2025 Long Term Incentive Plan 436,681* 27 March 2025 Nil 27 March 2028** 26 March 2035 2025 Long Term Incentive Plan 28,729* 19 June 2025 Nil 27 March 2028** 26 March 2035 2025 Deferred Share Bonus Plan 24,730 13 March 2025 Nil 13 March 2028 12 March 2035 2026 Long Term Incentive Plan 451,653* 17 March 2026 Nil 17 March 2029** 16 March 2036 Notes: * Subject to satisfaction of performance conditions. ** Subject to a two-year holding period following the stated vesting date. |
DEALINGS BY THE PERSON MAKING THE DISCLOSURE
The currency of all prices and other monetary amounts should be stated.
Purchases and sales
| Class of relevant security | Purchase/sale | Number of securities | Price per unit | ||||
| N/A | N/A | N/A | N/A | ||||
| Class of relevant security | Purchases/ sales | Total number of securities | Highest price per unit paid/received | Lowest price per unit paid/received | |||
| N/A | N/A | N/A | N/A | N/A | |||
| (b) Cash-settled derivative transactions | |||||||
| Class of relevant security | Product description e.g. CFD | Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position | Number of reference securities | Price per unit | |||
| N/A | N/A | N/A | N/A | N/A | |||
| (c) Stock-settled derivative transactions (including options) | |||||||
| (i) Writing, selling, purchasing or varying | |||||||
| Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates | Exercise price per unit | Type e.g. American, European etc. | Expiry date | Option money paid/ received per unit |
| N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| (ii) Exercise | |||||||
| Class of relevant security | Product description e.g. call option | Exercising/ exercised against | Number of securities | Exercise price per unit | |||
| N/A | N/A | N/A | N/A | N/A | |||
| (d) Other dealings (including subscribing for new securities) | |||||||
| Class of relevant security | Nature of dealing e.g. subscription, conversion | Details | Price per unit (if applicable) | ||||
| Ordinary shares of 1 pence each | Exercise of share awards under the 2023 Long Term Incentive Plan | 37,463 ordinary shares * | Nil | ||||
* Processed on a net settlement basis whereby Spire Healthcare Group plc settles the tax and national insurance liabilities in connection with the exercise of the share awards under the 2023 Long Term Incentive Plan and the remaining balance of shares are allocated to Harbant Samra. The number of shares allocated to Harbant Samra following satisfaction of the taxes due is 19,855.
- OTHER INFORMATION
- Indemnity and other dealing arrangements
None
- Agreements, arrangements or understandings relating to options or derivatives
None
Attachments
Are any Supplemental Forms attached?
| Supplemental Form 8 (Open Positions) | NO |
| Supplemental Form 8 (SBL) | NO |
| Date of disclosure: | 19 May 2026 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.